Skip to main content
Clinical Trials/NCT06325397
NCT06325397
Completed
Not Applicable

Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)

Matthew Rauen1 site in 1 country65 target enrollmentMarch 18, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Nuclear Cataract
Sponsor
Matthew Rauen
Enrollment
65
Locations
1
Primary Endpoint
Medication Rescue
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

To investigate the impact of high vs low Intraocular Pressure (IOP) on the intraoperative experience for the patient and surgeon. Operating at a more physiologic IOP using Active Sentry hand piece during cataract surgery will result in significantly less discomfort/pain as assessed by the decreased need for rescue medication

Detailed Description

Objectives: To investigate the impact of Intraocular Pressure (IOP) high vs low on the intraoperative experience for the patient and surgeon Design: Prospective, single-surgeon, subject's first eyes undergoing phacoemulsification will be randomized to high (Intraocular Pressure (IOP) 65 millimeters of mercury (mmHg)) or low (IOP 25mmHg) IOP, contralateral eye will receive other treatment Hypothesis: Operating at a more physiologic IOP using Active Sentry hand piece during cataract surgery will result in significantly less discomfort/pain as assessed by the decreased need for rescue medication

Registry
clinicaltrials.gov
Start Date
March 18, 2024
End Date
April 1, 2025
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Matthew Rauen
Responsible Party
Sponsor Investigator
Principal Investigator

Matthew Rauen

MD

Wolfe Eye Clinic

Eligibility Criteria

Inclusion Criteria

  • Visually significant cataract 2-3+ undergoing uncomplicated cataract surgery
  • Unremarkable ocular health but inclusive of early Age related macular degeneration (AMD).

Exclusion Criteria

  • History of ocular surgery including corneal refractive surgery
  • Compromised zonular integrity or stability
  • Uncontrolled diabetes and diabetic retinopathy
  • Small pupils
  • History of systemic inflammatory disease/uveitis
  • History of psychiatric illness, chronic pain/narcotics, benzodiazepine usage
  • Abnormal liver or renal function

Outcomes

Primary Outcomes

Medication Rescue

Time Frame: Intraoperative

Percentage (%) of pts in each group requiring treatment for breakthrough discomfort/pain

Secondary Outcomes

  • Surgeon Experience: Assessment on patient cooperation(Intraoperative)
  • Cost- analysis(Intraoperative)
  • Physiologic Responses associated with pain/inflammation:(Intraoperative)
  • Surgeon Experience: Surgeon intraoperative experience(Intraoperative)

Study Sites (1)

Loading locations...

Similar Trials